skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:052381/0156   Pages: 7
Recorded: 04/13/2020
Attorney Dkt #:122951.43
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 23
1
Patent #:
8168775
Issue Dt:
05/01/2012
Application #:
12582669
Filing Dt:
10/20/2009
Publication #:
US20100120893
Pub Dt:
05/13/2010
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN
2
Patent #:
8741866
Issue Dt:
06/03/2014
Application #:
13410262
Filing Dt:
03/01/2012
Publication #:
US20120225927
Pub Dt:
09/06/2012
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN
3
Patent #:
9133461
Issue Dt:
09/15/2015
Application #:
13835613
Filing Dt:
03/15/2013
Publication #:
US20130281511
Pub Dt:
10/24/2013
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
4
Patent #:
9234196
Issue Dt:
01/12/2016
Application #:
14220829
Filing Dt:
03/20/2014
Publication #:
US20140194493
Pub Dt:
07/10/2014
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TRANSTHYRETIN
5
Patent #:
9399775
Issue Dt:
07/26/2016
Application #:
14358972
Filing Dt:
05/16/2014
Publication #:
US20140315835
Pub Dt:
10/23/2014
Title:
RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
6
Patent #:
9631193
Issue Dt:
04/25/2017
Application #:
14391392
Filing Dt:
10/09/2014
Publication #:
US20150111841
Pub Dt:
04/23/2015
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
7
Patent #:
10125364
Issue Dt:
11/13/2018
Application #:
14814911
Filing Dt:
07/31/2015
Publication #:
US20160115476
Pub Dt:
04/28/2016
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
8
Patent #:
10119143
Issue Dt:
11/06/2018
Application #:
15027176
Filing Dt:
04/04/2016
Publication #:
US20160244766
Pub Dt:
08/25/2016
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
9
Patent #:
10570391
Issue Dt:
02/25/2020
Application #:
15188317
Filing Dt:
06/21/2016
Publication #:
US20160355817
Pub Dt:
12/08/2016
Title:
RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
10
Patent #:
10208307
Issue Dt:
02/19/2019
Application #:
15221651
Filing Dt:
07/28/2016
Publication #:
US20170029817
Pub Dt:
02/02/2017
Title:
TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
11
Patent #:
10240152
Issue Dt:
03/26/2019
Application #:
15380571
Filing Dt:
12/15/2016
Publication #:
US20170321213
Pub Dt:
11/09/2017
Title:
Compositions and Methods for Inhibiting Expression of Transthyretin
12
Patent #:
10400239
Issue Dt:
09/03/2019
Application #:
15457725
Filing Dt:
03/13/2017
Publication #:
US20180037886
Pub Dt:
02/08/2018
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
13
Patent #:
10968452
Issue Dt:
04/06/2021
Application #:
15473836
Filing Dt:
03/30/2017
Publication #:
US20170204418
Pub Dt:
07/20/2017
Title:
POLYNUCLEOTIDE AGENTS TARGETING AMINOLEVULINIC ACID SYNTHASE-1 (ALAS1) AND USES THEREOF
14
Patent #:
10060921
Issue Dt:
08/28/2018
Application #:
15507691
Filing Dt:
02/28/2017
Publication #:
US20170307608
Pub Dt:
10/26/2017
Title:
Methods of Treating Transthyretin (TTR) Mediated Amyloidosis
15
Patent #:
11079379
Issue Dt:
08/03/2021
Application #:
16054854
Filing Dt:
08/03/2018
Publication #:
US20190162724
Pub Dt:
05/30/2019
Title:
Methods of Treating Transthyretin (TTR) Mediated Amyloidosis
16
Patent #:
11028392
Issue Dt:
06/08/2021
Application #:
16137046
Filing Dt:
09/20/2018
Publication #:
US20190144870
Pub Dt:
05/16/2019
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
17
Patent #:
NONE
Issue Dt:
Application #:
16142953
Filing Dt:
09/26/2018
Publication #:
US20190218549
Pub Dt:
07/18/2019
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
18
Patent #:
10683501
Issue Dt:
06/16/2020
Application #:
16223362
Filing Dt:
12/18/2018
Publication #:
US20190345492
Pub Dt:
11/14/2019
Title:
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
19
Patent #:
NONE
Issue Dt:
Application #:
16468953
Filing Dt:
06/12/2019
Publication #:
US20190350962
Pub Dt:
11/21/2019
Title:
METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
20
Patent #:
NONE
Issue Dt:
Application #:
16514815
Filing Dt:
07/17/2019
Publication #:
US20200181614
Pub Dt:
06/11/2020
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
21
Patent #:
11806360
Issue Dt:
11/07/2023
Application #:
16648558
Filing Dt:
03/18/2020
Publication #:
US20210361692
Pub Dt:
11/25/2021
Title:
Compositions and Methods for Treating Transthyretin (TTR) Mediated Amyloidosis
22
Patent #:
NONE
Issue Dt:
Application #:
16738014
Filing Dt:
01/09/2020
Publication #:
US20200318111
Pub Dt:
10/08/2020
Title:
RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
23
Patent #:
NONE
Issue Dt:
Application #:
16751026
Filing Dt:
01/23/2020
Publication #:
US20200283766
Pub Dt:
09/10/2020
Title:
Compositions and Methods for Inhibiting Expression of Transthyretin
Assignor
1
ALNYLAM PHARMACEUTICALS, INC.
Exec Dt:
04/10/2020
Assignee
1
WILMINGTON TRUST, NATIONAL ASSOCIATION
50 SOUTH SIXTH STREET
SUITE 1290
MINNEAPOLIS, MINNESOTA 55402
Correspondence name and address
SPENCER SIMON
787 SEVENTH AVENUE
NEW YORK, NY 10019

Search Results as of: 05/28/2024 11:32 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT